RadNet, Inc. last reported quarterly results on Aug 10, 2026, for Q2 FY2026 (the quarter ended Jun 30, 2026): revenue of $622.7 million (+25.0% year over year) and diluted EPS of $0.10. It usually reports 41–61 days after a quarter ends. Based on that pattern, the next release is estimated for around Nov 9, 2026.
Results for Q3 FY2026, the quarter ending around Sep 30, 2026. Expected on a Monday. Based on last year's release for the same quarter on Nov 10, 2025. This is an estimate, not a date the company has announced.
Release dates are when the company filed its earnings announcement with the SEC (Form 8-K, Item 2.02); select a date to open the filing. It usually reports 41–61 days after a quarter ends. Figures are USD in millions, except EPS. The colored percent is the change from the same quarter a year earlier. Until a quarter's 10-Q or 10-K figures reach the SEC's data, they come from the earnings press release, and are shown only when its year-ago numbers match the filed ones. A dash means the figure could not be confirmed yet.
| Released | Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|---|
|
Aug 10, 2026
41 days after quarter end
|
Q2 FY2026
ended Jun 30, 2026
|
623
+25.0%
|
8
-47.9%
|
0.10
-47.4%
|
|
May 11, 2026
41 days after quarter end
|
Q1 FY2026
ended Mar 31, 2026
|
576
+22.1%
|
-33
+11.8%
|
-0.43
+15.7%
|
|
Mar 2, 2026
61 days after quarter end
|
Q4 FY2025
ended Dec 31, 2025
|
548
+14.8%
|
-1
-111.2%
|
-0.01
-111.8%
|
|
Nov 10, 2025
41 days after quarter end
|
Q3 FY2025
ended Sep 30, 2025
|
523
+13.4%
|
5
+68.8%
|
0.07
+75.0%
|
|
Aug 11, 2025
42 days after quarter end
|
Q2 FY2025
ended Jun 30, 2025
|
498
+8.4%
|
14
+584.7%
|
0.19
+575.0%
|
|
May 12, 2025
42 days after quarter end
|
Q1 FY2025
ended Mar 31, 2025
|
471
+9.2%
|
-38
-1264.7%
|
-0.51
-1175.0%
|
|
Mar 5, 2025
64 days after quarter end
|
Q4 FY2024
ended Dec 31, 2024
|
477
+13.5%
|
5
+387.4%
|
0.07
+343.8%
|
|
Nov 12, 2024
43 days after quarter end
|
Q3 FY2024
ended Sep 30, 2024
|
461
+14.7%
|
3
-81.7%
|
0.04
-84.0%
|
Company profile
- Industry
- Services-Medical Laboratories (SIC 8071)
- Listed as
- RDNT (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Los Angeles, CA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 790526
- Former names
- RadNet, Inc. (until Oct 26, 2026); PRIMEDEX HEALTH SYSTEMS INC (until Nov 21, 2006)
Other Services-Medical Laboratories companies
- Natera, Inc. NTRA
- Labcorp Holdings Inc. LH
- Quest Diagnostics Inc DGX
- Guardant Health, Inc. GH
- Caris Life Sciences, Inc. CAI
- GRAIL, Inc. GRAL
- BillionToOne, Inc. BLLN
- CareDx, Inc. CDNA
Source: SEC EDGAR filings. This is company-reported data, not investment advice.